TY - JOUR
T1 - Non-parathyroid hypercalcemia associated with paraffin oil injection in 12 younger male bodybuilders
AU - Sølling, Anne Sophie
AU - Tougaard, Birgitte
AU - Harsløf, Torben
AU - Langdahl, Bente
AU - Kongsbak Brockstedt, Helle
AU - Byg, Keld-Erik
AU - Ivarsen, Per
AU - Karstoft Ystrøm, Ina
AU - Holden Mose, Frank
AU - Lissel Isaksson, Gustaf
AU - Steen Svarer Hansen, Morten
AU - Nagarajah, Subagini
AU - Ejersted, Charlotte
AU - Bendstrup, Elisabeth
AU - Rejnmark, Lars
PY - 2018/6
Y1 - 2018/6
N2 - INTRODUCTION: Injection of paraffin oil to augment muscles size is a troubling phenomenon known to cause a foreign-body reaction with formation of granulomas. In a few case-reports, long-term side effects have been reported in terms of hypercalcemia and renal failure.METHODS: We identified a case series of 12 male bodybuilders presenting with non-parathyroid hypercalcemia who previously had injected paraffin oil to increase muscles size.RESULTS: At admission, all patients had moderate to severe hypercalcemia with suppressed PTH levels and impaired renal function. Calcitriol levels were within the normal range or slightly elevated. Follow up measurements showed marked hypercalciuria with nearly normal levels of bone turnover markers. A correlation was found between levels of peptidyl-dipeptidase and calcitriol (R=0.812, p= 0.050). Treatment with antiresorptive agents seemed less effective than glucocorticoids, which resulted in a significantly lowering of ionized calcium levels and improved renal function, although no patients were cured by this treatment. Immunosuppression with azathioprine or mycophenolate may have a glucocorticoid-saving effect. One patient had surgery with removal of affected muscle tissue, without any apparent effect on plasma calcium levels.CONCLUSION: The hypercalcemia and associated hypercalciuria seems to be due to an intestinal hyperabsorption of calcium. It remains to be elucidated, whether an increased calcitriol synthesis within granulomas is the only (main) mechanism by which intestinal calcium absorption is increased. Glucocorticoids seem most appropriate as the first choice for treatment. Bodybuilders should be warned against use of intramuscular oil injections (and other substances), as this may have severe adverse health consequences.
AB - INTRODUCTION: Injection of paraffin oil to augment muscles size is a troubling phenomenon known to cause a foreign-body reaction with formation of granulomas. In a few case-reports, long-term side effects have been reported in terms of hypercalcemia and renal failure.METHODS: We identified a case series of 12 male bodybuilders presenting with non-parathyroid hypercalcemia who previously had injected paraffin oil to increase muscles size.RESULTS: At admission, all patients had moderate to severe hypercalcemia with suppressed PTH levels and impaired renal function. Calcitriol levels were within the normal range or slightly elevated. Follow up measurements showed marked hypercalciuria with nearly normal levels of bone turnover markers. A correlation was found between levels of peptidyl-dipeptidase and calcitriol (R=0.812, p= 0.050). Treatment with antiresorptive agents seemed less effective than glucocorticoids, which resulted in a significantly lowering of ionized calcium levels and improved renal function, although no patients were cured by this treatment. Immunosuppression with azathioprine or mycophenolate may have a glucocorticoid-saving effect. One patient had surgery with removal of affected muscle tissue, without any apparent effect on plasma calcium levels.CONCLUSION: The hypercalcemia and associated hypercalciuria seems to be due to an intestinal hyperabsorption of calcium. It remains to be elucidated, whether an increased calcitriol synthesis within granulomas is the only (main) mechanism by which intestinal calcium absorption is increased. Glucocorticoids seem most appropriate as the first choice for treatment. Bodybuilders should be warned against use of intramuscular oil injections (and other substances), as this may have severe adverse health consequences.
UR - http://www.scopus.com/inward/record.url?scp=85046574083&partnerID=8YFLogxK
U2 - 10.1530/EJE-18-0051
DO - 10.1530/EJE-18-0051
M3 - Journal article
C2 - 29599408
SN - 0804-4643
VL - 198
SP - 29
EP - 37
JO - European Journal of Endocrinology
JF - European Journal of Endocrinology
IS - 6
ER -